Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | CA4 | P22748 | 2/20 | 0.56 |
| ▸ | CA9 | Q16790 | 2/20 | 0.56 |
| ▸ | FDPS | P14324 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 3/20 | 0.46 |
| ▸ | BCHE | P06276 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13164750 | 1.00 | CA12 (0.56) | CA12CA1CA2CA4CA9 | |
| SCHEMBL13164753 | 0.94 | FDPS (0.59) | CA12CA1CA2CA4CA9 | |
| SCHEMBL18993901 | 0.94 | CA12 (0.57) | CA12CA1CA2CA4CA9 | |
| SCHEMBL15693396 | 0.93 | CA12 (0.56) | CA12CA1CA2CA4CA9 | |
| SCHEMBL18993902 | 0.93 | CA12 (0.53) | CA12CA1CA2CA4CA9 | |
| SCHEMBL14232135 | 0.92 | CA12 (0.57) | CA12CA1CA2CA4CA9 | |
| SCHEMBL13091335 | 0.91 | CA12 (0.48) | CA12CA1CA2CA4CA9 | |
| SCHEMBL18993904 | 0.90 | CA12 (0.54) | CA12CA1CA2CA4CA9 | |
| SCHEMBL23938694 | 0.90 | FDPS (0.55) | CA12CA1CA2CA4CA9 | |
| SCHEMBL21989443 | 0.90 | CA12 (0.53) | CA12CA1CA2CA4CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7794802-B2 | Polymerizable liquid crystal compound, composition and polymer | CHISSO CORPORATION (JP) | 2010-09-14 | — | — | US | disclosed |
| US-20100076171-A1 | Polymerizable liquid crystal compound, composition and polymer | CHISSO CORPORATION | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076171-A1 | Polymerizable liquid crystal compound, composition and polymer | LSS, SFXN1, FRG1 | CA12 2797/4885CA1 1290/4885CA2 3412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.